NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Reddit, Inc. (NYSE: RDDT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Reddit, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/reddit-inc-securities-fraud-class-action. Investors have until August 18, 2025, to ask the Court to ...

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Sarepta Therapeutics, Inc. (NASDAQ: SRPT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Sarepta, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/sarepta-therapeutics-inc-class-action. Investors have until August 25, 2025, to as ...

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in RxSight, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/rxsight-inc-class-action-lawsuit. Investors have until September 22, 2025, to ask the Court to ...

Palo Alto Networks will take over Israeli identity security provider CyberArk in a deal valued at roughly $25 billion.The California-based cybersecurity company will pay $45 a share for CyberArk, representing a 26% premium to its share price Friday.Shares of Palo Alto fell more than 7% before the bell Wednesday, building on a 5% loss from Tuesday. CyberArk's stock dipped 2%.Palo Alto Networks intends to use the deal to officially penetrate the identity security market and improve its multi-layer offering fo ...

Core Insights - Newmont Corporation (NEM) achieved a significant milestone by reducing its all-in sustaining costs (AISC) to $1,593 per ounce in Q2 2025, a 4% decrease from the previous quarter, primarily due to lower direct operating costs and sustaining capital spending [1][6] - Despite the reduction, NEM anticipates a modest increase in AISC for its core portfolio in Q3 2025 due to higher sustaining capital spending, with a full-year guidance of $1,630 per ounce for 2025, up from $1,516 per ounce in 2024 [2][6] - NEM's operational efficiency is highlighted by its ability to lower AISC amid industry-wide cost pressures, contrasting with peers like Barrick Mining Corporation, which experienced a 22% increase in AISC to $1,775 per ounce in Q1 2025 [2][3] Financial Performance - NEM's shares have surged 71.9% year-to-date, outperforming the Zacks Mining – Gold industry's rise of 55.4%, largely driven by a rally in gold prices [5] - The Zacks Consensus Estimate indicates a year-over-year earnings rise of 39.4% for 2025 and 3.1% for 2026, with EPS estimates trending higher over the past 60 days [7] Valuation Metrics - NEM is currently trading at a forward 12-month earnings multiple of 13.21, representing a 6.5% premium to the industry average of 12.4X, and carries a Value Score of B [8]

Core Insights - Aris Mining Corporation (ARMN) reported a strong first-quarter performance driven by increased gold sales volumes, leading to significant revenue and earnings growth [1][2] Group 1: Sales and Revenue Performance - ARMN's gold sales increased by approximately 6% year-over-year to 54,281 ounces in the first quarter, reflecting operational efficiency and improved output from Colombian assets [2][8] - The rise in sales volumes resulted in a 47% year-over-year increase in gold revenues, reaching a record $157.5 million, and a 137% surge in earnings from mine operations [2][8] Group 2: Comparative Performance - In contrast, B2Gold Corp. (BTG) experienced a 17% decline in gold sales to 183,998 ounces in the same quarter, while AngloGold Ashanti plc (AU) reported an 18% increase in gold sales volumes [3][4] Group 3: Stock Performance and Valuation - ARMN's stock has surged by 105.4% year-to-date, outperforming the Zacks Mining – Gold industry's increase of 55.4% [5][8] - The company is currently trading at a forward 12-month earnings multiple of 4.08, which is about 67% lower than the industry average of 12.4X, indicating a potential undervaluation [9][8] Group 4: Earnings Estimates - The Zacks Consensus Estimate projects ARMN's earnings to rise by 264.7% in 2025 and 73.8% in 2026, with EPS estimates trending higher over the past 60 days [10]

– New patent enhances market position in Europe HOUSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced it has received a Notice of Intent to Grant for the European patent application titled, “PREPARATION OF PRELIPOSOMAL ANNAMYCIN LYOPHILIZATE.“ Such grant should solidify the Company’s European Union exclusivity o ...

Core Insights - Amazon and Whole Foods Market released their annual sustainability and impact reports, highlighting their commitment to environmental efforts and recognizing Windfall Bio for its innovative methane transformation technology [1][2] Company Overview - Windfall Bio utilizes natural soil microbes, known as mems, to convert methane into high-value organic fertilizer, addressing the significant warming potential of methane, which is over 86 times greater than carbon dioxide over a 20-year period [1][6] - The company was founded in 2022 and is based in San Mateo, California, backed by prominent venture capital firms including Amazon's Climate Pledge Fund [7] Pilot Projects - Windfall Bio successfully piloted its methane transformation technology at two dairy farms, Straus Family Creamery and Darigold, demonstrating a pathway for food retailers to reduce Scope 3 emissions while generating economic returns from organic fertilizer production [2][3] Collaboration and Funding - The collaboration between Whole Foods Market and Windfall Bio facilitated the pilot projects, supported by funding from Amazon's Climate Pledge Fund, which helped develop the necessary infrastructure [3][4] - Windfall Bio was selected as a fellow in the 2025 cohort of the Compute for Climate Fellowship, providing startups with advanced computing services to scale their operations [4][8] Industry Impact - The innovative approach of Windfall Bio presents a model for consumer packaged goods (CPG) companies and food retailers to transform methane emissions into valuable resources, contributing to more resilient supply chains [4]

Company Overview - Graphjet Technology is an innovative producer of graphene and graphite, founded in 2019 in Malaysia, utilizing patented technology to recycle palm kernel shells into single-layer graphene and artificial graphite [5] Recent Developments - The company successfully received new machinery and equipment at its factory in Malaysia, which is expected to enhance production capabilities significantly [1][2] - A specialist from the supplier is on-site to install and commission the new equipment, with installation expected to be completed within a week [2] Production Capacity and Market Demand - The new machinery is projected to increase production capacity by approximately seven times, aligning with the growing demand for graphite and graphene, particularly in the semiconductor industry [4] - The expansion of advanced semiconductor manufacturing, driven by the demand for specialized chips, presents a favorable market environment for Graphjet [3][4] Strategic Positioning - Graphjet's sustainable production methods using agricultural waste position the company to potentially transform the global graphite and graphene supply chain [5]

Real-world data showing NeuroStar is effective in adolescents and young adults with depression from the world’s largest TMS outcomes datasetMALVERN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced the publication of significant real-world findings in the Journal of the American Academy of Child & Adolesce ...